These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30343664)

  • 1. Analysis of drug resistance in HIV protease.
    Pawar SD; Freas C; Weber IT; Harrison RW
    BMC Bioinformatics; 2018 Oct; 19(Suppl 11):362. PubMed ID: 30343664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of drug resistance in HIV protease.
    Shah D; Freas C; Weber IT; Harrison RW
    BMC Bioinformatics; 2020 Dec; 21(Suppl 18):497. PubMed ID: 33375936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated prediction of HIV drug resistance from genotype data.
    Shen C; Yu X; Harrison RW; Weber IT
    BMC Bioinformatics; 2016 Aug; 17 Suppl 8(Suppl 8):278. PubMed ID: 27586700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of HIV drug resistance based on the 3D protein structure: Proposal of molecular field mapping.
    Ota R; So K; Tsuda M; Higuchi Y; Yamashita F
    PLoS One; 2021; 16(8):e0255693. PubMed ID: 34347839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
    Lefebvre E; Schiffer CA
    AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of HIV drug resistance from genotype with encoded three-dimensional protein structure.
    Yu X; Weber IT; Harrison RW
    BMC Genomics; 2014; 15 Suppl 5(Suppl 5):S1. PubMed ID: 25081370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of HIV-1 protease inhibitor resistance using a protein-inhibitor flexible docking approach.
    Jenwitheesuk E; Samudrala R
    Antivir Ther; 2005; 10(1):157-66. PubMed ID: 15751773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the full length HIV-1 Gag polyprotein reveals the role of its p6 subunit in viral maturation and the effect of non-cleavage site mutations in protease drug resistance.
    Su CT; Kwoh CK; Verma CS; Gan SK
    J Biomol Struct Dyn; 2018 Dec; 36(16):4366-4377. PubMed ID: 29237328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly drug-resistant HIV-1 protease reveals decreased intra-subunit interactions due to clusters of mutations.
    Kneller DW; Agniswamy J; Harrison RW; Weber IT
    FEBS J; 2020 Aug; 287(15):3235-3254. PubMed ID: 31920003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting HIV drug resistance with neural networks.
    Drăghici S; Potter RB
    Bioinformatics; 2003 Jan; 19(1):98-107. PubMed ID: 12499299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV genotype mutations evoked by nelfinavir-based regimens: frequency, background, and consequences on subsequent treatment options.
    Manfredi R; Calza L
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):258-60. PubMed ID: 12045690
    [No Abstract]   [Full Text] [Related]  

  • 12. Sequence and structure based models of HIV-1 protease and reverse transcriptase drug resistance.
    Masso M; Vaisman II
    BMC Genomics; 2013; 14 Suppl 4(Suppl 4):S3. PubMed ID: 24268064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: implications for inhibitor design.
    Velazquez-Campoy A; Muzammil S; Ohtaka H; Schön A; Vega S; Freire E
    Curr Drug Targets Infect Disord; 2003 Dec; 3(4):311-28. PubMed ID: 14754432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying representative drug resistant mutants of HIV.
    Yu X; Weber IT; Harrison RW
    BMC Bioinformatics; 2015; 16 Suppl 17(Suppl 17):S1. PubMed ID: 26678327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat.
    Fun A; van Maarseveen NM; Pokorná J; Maas RE; Schipper PJ; Konvalinka J; Nijhuis M
    Retrovirology; 2011 Aug; 8():70. PubMed ID: 21864346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GS-8374, a prototype phosphonate-containing inhibitor of HIV-1 protease, effectively inhibits protease mutants with amino acid insertions.
    Grantz Šašková K; Kozíšek M; Stray K; de Jong D; Rezáová P; Brynda J; van Maarseveen NM; Nijhuis M; Cihlár T; Konvalinka J
    J Virol; 2014 Mar; 88(6):3586-90. PubMed ID: 24371077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessory mutations maintain stability in drug-resistant HIV-1 protease.
    Chang MW; Torbett BE
    J Mol Biol; 2011 Jul; 410(4):756-60. PubMed ID: 21762813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistance.
    Su CT; Ling WL; Lua WH; Haw YX; Gan SK
    BMC Bioinformatics; 2016 Dec; 17(Suppl 19):500. PubMed ID: 28155724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice.
    Romano L; Venturi G; Giomi S; Pippi L; Valensin PE; Zazzi M
    J Med Virol; 2002 Feb; 66(2):143-50. PubMed ID: 11782921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tackling the problem of HIV drug resistance.
    Weber IT; Harrison RW
    Postepy Biochem; 2016; 62(3):273-279. PubMed ID: 28132481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.